These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 21207489)
1. The end of drugging children: toward the genealogy of the ADHD subject. Comstock EJ J Hist Behav Sci; 2011; 47(1):44-69. PubMed ID: 21207489 [TBL] [Abstract][Full Text] [Related]
2. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder. Foy JM; Earls MF Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972 [TBL] [Abstract][Full Text] [Related]
3. The early history of the neuroscience of attention-deficit/hyperactivity disorder. Baumeister AA; Henderson K; Pow JL; Advokat C J Hist Neurosci; 2012 Jul; 21(3):263-79. PubMed ID: 22724488 [TBL] [Abstract][Full Text] [Related]
4. Suffer the restless children: the evolution of ADHD and paediatric stimulant use, 1900-80. Mayes R; Rafalovich A Hist Psychiatry; 2007 Dec; 18(72 Pt 4):435-57. PubMed ID: 18590022 [TBL] [Abstract][Full Text] [Related]
10. Effects of methylphenidate on subtypes of attention-deficit/hyperactivity disorder. Gorman EB; Klorman R; Thatcher JE; Borgstedt AD J Am Acad Child Adolesc Psychiatry; 2006 Jul; 45(7):808-16. PubMed ID: 16832317 [TBL] [Abstract][Full Text] [Related]
11. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review. Findling RL Clin Ther; 2008 May; 30(5):942-57. PubMed ID: 18555941 [TBL] [Abstract][Full Text] [Related]
12. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder. Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858 [TBL] [Abstract][Full Text] [Related]
13. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study. Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731 [TBL] [Abstract][Full Text] [Related]
14. Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample. Yang P; Hsu HY; Chiou SS; Chao MC Aust N Z J Psychiatry; 2007 Dec; 41(12):998-1004. PubMed ID: 17999272 [TBL] [Abstract][Full Text] [Related]
15. [Graphomotor functions in children with attention deficit hyperactivity disorder (ADHD)]. Stasik D; Tucha O; Tucha L; Walitza S; Lange KW Psychiatr Pol; 2009; 43(2):183-92. PubMed ID: 19697788 [TBL] [Abstract][Full Text] [Related]
16. Predicting methylphenidate response in children with ADHD: theoretical, empirical, and conceptual models. Denney CB; Rapport MD J Am Acad Child Adolesc Psychiatry; 1999 Apr; 38(4):393-401. PubMed ID: 10199110 [TBL] [Abstract][Full Text] [Related]
17. Effects of methylphenidate on quality of life in children with both developmental coordination disorder and ADHD. Flapper BC; Schoemaker MM Dev Med Child Neurol; 2008 Apr; 50(4):294-9. PubMed ID: 18352997 [TBL] [Abstract][Full Text] [Related]
19. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study. Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137 [TBL] [Abstract][Full Text] [Related]
20. Attention-deficit/hyperactivity disorder: a personal perspective. Ginsberg ML Adolesc Med State Art Rev; 2008 Aug; 19(2):339-51, xi-xii. PubMed ID: 18822837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]